MarketScreener Homepage > News > Sectors > Healthcare

News : Sectors

KONINKLIJKE PHILIPS N.V.

Philips growth spurred by COVID-19 demand and distant care

ASTRAZENECA PLC

Wins two approval recommendations from EU agency

MARTIN SCICLUNA

RSA chairman Martin Scicluna to step down next year - Sky News

10/19	Moderna CEO Expects Covid-19 Vaccine Interim Results in November	DJ
10/19	Moderna CEO Expects Covid-19 Vaccine Interim Results in November	DJ
10/19	JIANGSU HENGRUI MEDICINE : Nine-Month Net Profit Rose 14%	DJ
10/19	Bayer's Orbia plans Latam expansion after Bunge deal in Brazil	RE
10/19	Philips growth spurred by COVID-19 demand and distant care	RE
10/19	France's Ose to enrol up to 400 for 'T-cell' coronavirus vaccine trials	RE
10/19	France's Ose to enroll up to 400 for 'T-cell' coronavirus vaccine trials	RE
10/19	China's Sinovac vaccine is safe, Brazil institute says	RE
10/19	Brazil's Butantan says tests show vaccine by China's Sinovac is safe	RE
10/19	ABBVIE : Seeks U.S., European OK of Rinvoq in Eczema	DJ
10/19	BAYER AG : UBS keeps its Buy rating	MD
10/19	ASTRAZENECA : Receives a Sell rating from Goldman Sachs	MD
10/19	GERRESHEIMER AG : Gets a Sell rating from DZ Bank	MD
10/19	ELI LILLY : Health Canada Approves Taltz for Non-Radiographic Axial Spondyloarthritis	DJ
10/19	CVS HEALTH : to Hire 15,000 Employees in the U.S. in 4Q	DJ

The best opportunities.
All the markets. Each month. In one click.

Discover

10/19	PHILIPS NV : Goldman Sachs remains its Buy rating	MD
10/19	PHILIPS NV : Kepler Cheuvreux gives a Neutral rating	MD
10/19	DRAEGERWERK : Independant Research gives a Neutral rating	MD
10/19	BRISTOL MYERS SQUIBB : Exelixis Get Priority Review for Kidney-Cancer Treatment	DJ
10/19	LabCorp launches test to measure COVID-19 antibodies in clinical trials	RE
10/19	FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Warburg Research gives a Neutral rating	MD
10/19	ROCHE HOLDINGS AG : JP Morgan reaffirms its Buy rating	MD
10/19	KONINKLIJKE PHILIPS N : Philips 3Q Net Profit Rose as Sales Returned to Growth -- Update	DJ
10/19	DERMAPHARM : Berenberg reiterates its Buy rating	MD
10/19	PHILIPS NV : Bernstein reiterates its Buy rating	MD
10/19	PHILIPS NV : JP Morgan reaffirms its Neutral rating	MD
10/19	EVOTEC : Baader Bank keeps its Buy rating	MD
10/19	SANOFI : Gets a Buy rating from Goldman Sachs	MD
10/19	SHIELD THERAPEUTICS : Peer Teva Pharmaceutical Industries Withdraws Oppositions to Patents	DJ
10/19	EVOTEC : secures grant to evaluate antibody drugs for COVID-19	RE
10/19	ASTRAZENECA : wins two approval recommendations from EU agency	RE
10/19	KONINKLIJKE PHILIPS N : Philips 3Q Net Profit Rose; Targets Higher Profitability for 2021-2025	DJ
10/18	SHANGHAI JUNSHI BIOSCIENCES : May Benefit From Covid-19 Neutralising Antibody	DJ
10/18	SERUM INSTITUTE, BHARAT BIOTECH TO BEGIN TRIAL OF INTRANASAL COVID-19 VACCINE SOON : Vardhan	RE
10/17	TOP GLOVE BHD : Malaysia has inspected, will monitor rubber manufacturers' labour law compliance	RE
10/17	DR REDDY LABORATORIES : Russia receives renewed approval for COVID-19 vaccine trials in India -RDIF	RE
10/16	Pfizer says earliest U.S. filing for COVID-19 vaccine would be late November	RE
10/16	GILEAD SCIENCES : WHO-Backed Study Finds No Remdesivir Benefit for Hospitalized Covid-19 Patients -- Update	DJ
10/16	GILEAD SCIENCES : FDA Says Remdesivir EUA Letter Of Authorization, Reissued Oct 16	RE
10/16	Confirmed Coronavirus Cases in U.S. Surpass 8 Million -- 4th Update	DJ
10/16	Confirmed Coronavirus Cases in U.S. Surpass 8 Million -- 4th Update	DJ
10/16	GILEAD SCIENCES : WHO-Backed Study Finds No Remdesivir Benefit for Hospitalized Covid-19 Patients	DJ
10/16	CVS HEALTH : Preparing to Provide Covid Vaccine to Long-Term Care Facilities When Available	DJ
10/16	PFIZER INC : RBC reiterates its Buy rating	MD
10/16	NOVO NORDISK : Buy rating from Goldman Sachs	MD
10/16	CVS HEALTH : Walgreens to Get Government Vaccine Deal for Long-Term Care Facilities -Politico	DJ
10/16	EXPLAINER : When will COVID-19 vaccines be generally available in the United States?	RE
10/16	GILEAD SCIENCES : EU urged to review remdesivir supply deal after COVID-19 trial results	RE
10/16	Pfizer Could Apply for Emergency Use of Covid-19 Vaccine by Late November -- Update	DJ
10/16	REGENERON PHARMACEUTICALS : Sanofi Get CHMP Backing for Dupixent in Children With Severe Atopic Dermatitis	DJ
10/16	JOHNSON & JOHNSON : J&J's Janssen Gets CHMP Positive Opinion for Tremfya in Active Psoriatic Arthritis	DJ
10/16	GILEAD SCIENCES : Kite Says CHMP Adopts Positive Opinion for Lymphoma Drug	DJ
10/16	BRISTOL MYERS SQUIBB : Gets Positive CHMP Opinion for Opdivo in Esophageal Cancer	DJ
10/16	NIH to Study Three Drugs in Treatment of Covid-19 Patients	DJ
10/16	Pfizer Could Apply for Emergency Use of Covid-19 Vaccine by Late November -- 2nd Update	DJ
10/16	Pfizer Could Apply for Emergency Use of Covid-19 Vaccine by Late November -- Update	DJ
10/16	Pfizer Could Apply for Emergency Use of Covid-19 Vaccine by Late November -- Update	DJ
10/16	ANALYSIS : Sales of first big COVID-19 drug, remdesivir, may disappoint	RE
10/16	Pfizer Could Apply for Emergency Use of Covid-19 Vaccine by Late November	DJ
10/16	ROCHE HOLDINGS AG : UBS keeps its Buy rating	MD
10/16	Physiomics Wins Contracts With Existing Customers	DJ
10/16	ROCHE HOLDINGS AG : Bernstein maintains a Buy rating	MD
10/16	DRAEGERWERK : Buy rating from Hauck & Aufhauser	MD
10/16	ROCHE HOLDINGS AG : Credit Suisse remains Neutral	MD
10/15	GILEAD SCIENCES : Issues Statement On Solidarity Trial	RE

The best opportunities.
All the markets. Each month. In one click.

Discover

10/15	GILEAD SCIENCES : WHO Says Solidarity Therapeutics Trial Produces Conclusive Evidence On Effectiveness Of Repurposed Drugs For COVID-19 In Record Time	RE
10/15	Gilead questions WHO study that cast doubts on drug's COVID-19 benefits	RE
10/15	GALAPAGOS : Servier Knee Osteoarthritis Trial Fails to Meet Primary, Secondary Endpoints	DJ
10/15	INTUITIVE SURGICAL : Reports Lower 3Q Profit, Revenue Amid Pandemic -- Earnings Review	DJ
10/15	PFIZER : BioNTech Race to Meet Global Covid-19 Vaccine Needs	DJ

1 2 3 4 5 6 7 8 9 10 Next

MOST READ NEWS

1	NETFLIX, INC. : Global equities decline on COVID lockdown fears
2	EURONEXT N.V. : Euronext plagued by two glitches Monday, latest exchange to go down
3	INTEL CORPORATION : Intel Enters Deal to Sell NAND Memory Unit to SK Hynix --Update
4	IBM posts double-digit cloud revenue growth; says customers deferring some projects
5	SK HYNIX, INC. : South Korea's SK Hynix to buy Intel's NAND business for $9 billion

More news